Remote loading paclitaxel-doxorubicin prodrug into liposomes for cancer combination therapy
The combination of paclitaxel (PTX) and doxorubicin (DOX) has been widely used in the clinic. However, it remains unsatisfied due to the generation of severe toxicity. Previously, we have successfully synthesized a prodrug PTX-S-DOX (PSD). The prodrug displayed comparable in vitro cytotoxicity compa...
Saved in:
Main Authors: | Jiang Yu (Author), Yingli Wang (Author), Shuang Zhou (Author), Jinbo Li (Author), Jiamei Wang (Author), Dongxu Chi (Author), Xue Wang (Author), Guimei Lin (Author), Zhonggui He (Author), Yongjun Wang (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A facile and universal method to achieve liposomal remote loading of non-ionizable drugs with outstanding safety profiles and therapeutic effect
by: Shuang Zhou, et al.
Published: (2021) -
Iron-doxorubicin prodrug loaded liposome nanogenerator programs multimodal ferroptosis for efficient cancer therapy
by: Yinxian Yang, et al.
Published: (2021) -
Optimized 5-Fluorouridine Prodrug for Co-Loading with Doxorubicin in Clinically Relevant Liposomes
by: Debra Wu, et al.
Published: (2021) -
Ratiometric delivery of doxorubicin and berberine by liposome enables superior therapeutic index than DoxilⓇ
by: Ruoshi Zhang, et al.
Published: (2020) -
Bioresponsive albumin-conjugated paclitaxel prodrugs for cancer therapy
by: Jincheng Yang, et al.
Published: (2018)